What is the cure rate of mid-term symptoms of liver cancer

Liver cancer is one of the most harmful malignant tumors to human health in the world. For liver cancer patients and their families, the question they want to clarify is: what is the cure rate of mid-term symptoms of liver cancer? The cure rates of early, middle and late stage liver cancer are different. We divide the cure rate of liver cancer into two stages: early and middle and late stages.

The cure rate of early liver cancer describes that the survival period of advanced liver cancer with ascites and jaundice is 3-6 months. Therefore, if the treatment of the tumor is delayed, not only will the treatment cost increase exponentially, but the cure rate will also be greatly reduced. In view of this, the treatment of the tumor must race against time and must be "early detection, early diagnosis, and early treatment."

Relevant experts pointed out that taking anti-cancer Chinese medicine for systemic treatment immediately after the tumor is diagnosed can seize precious treatment time and greatly improve the chances of recovery for cancer patients.

In the late stage of liver cancer, there will be progressive weight loss, fever, loss of appetite, fatigue, malnutrition and cachexia. A small number of patients with liver disease may have special systemic manifestations, called paraneoplastic syndrome, with hypoglycemia and polycythemia being the most common, and other rare ones include hypercalcemia, hyperlipidemia, carcinoid, etc.

If metastasis occurs to the lungs, bones, chest cavity, etc., corresponding symptoms may occur. Chest cavity metastasis is more common on the right side, and there may be signs of pleural effusion. Bone or spinal metastasis may cause local tenderness or nerve compression symptoms, and intracranial metastatic cancer may have nerve localization signs. Because the cure rate of advanced liver cancer is low, treatment can be targeted to relieve the patient's pain and prolong the survival period, so as to achieve the goal of living with the tumor. At the same time, the patient's will to survive is required, and the stronger the will, the better.